Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Safety assessment of potential probiotic Lactobacillus acidophilus AM13-1 with high cholesterol-lowering capability isolated from human gut.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Liu, Xudong; Wang, Mengmeng; Hu, Tongyuan; Lin, Xiaoqian; Liang, Hewei; Li, Wenxi; Zhao, Shaowei; Zhong, Yiyi; Zhang, Haifeng; Ge, Lan; Jin, Xin; Xiao, Liang; Zou, Yuanqiang
- Source:
Letters in Applied Microbiology; Jan2024, Vol. 77 Issue 1, p1-8, 8p
- Subject Terms:
- Additional Information
- Abstract:
An important risk factor for cardiovascular disease is dyslipidemia, especially abnormal cholesterol levels. The relation between probiotics and cholesterol-lowering capability has been extensively studied. Lactobacillus acidophilus plays a significant role in affecting host health, and produces multitudinous metabolites, which have prohibitory functions against pathogenic microorganisms. In this study, we identified a cholesterol-lowering strain AM13-1, isolated from a fecal sample obtained from a healthy adult male, and performed comprehensive function analysis by whole-genome analysis and in vitro experiments. Genome analyses of L. acidophilus AM13-1 revealed that carbohydrate and amino acid transport, metabolism, translation, ribosomal structure, and biogenesis are abundant categories of functional genes. No virulence factors or toxin genes with experimentally verified were found in the genome of strain AM13-1. Besides, plenty of probiotic-related genes were predicted from the L. acidophilus AM13-1 genome, such as cbh, atp A-D, and dlt D, with functions related to cholesterol-lowering and acid resistance. And strain AM13-1 showed high-efficiency of bile salt hydrolase activity and the capacity for removing cholesterol with efficiency rates of 70%. These function properties indicate that strain AM13-1 can be considered as a probiotic candidate for use in food and health care products. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of Letters in Applied Microbiology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.